Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D
The experimentally established mechanism targets of Leucine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.67 |
| ▸ | SLC1A3 | P43003 | 5/20 | 0.53 |
| ▸ | SLC1A2 | P43004 | 5/20 | 0.53 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.46 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.44 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.44 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.44 |
| ▸ | PGR | P06401 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | HTR2B | P41595 | 1/20 | 0.44 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.44 |
| ▸ | GRIK1 | P39086 | 6/20 | 0.42 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.41 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.41 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.41 |
| ▸ | GRIK3 | Q13003 | 2/20 | 0.41 |
| ▸ | GRIK5 | Q16478 | 2/20 | 0.41 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Leucine SCHEMBL27607014 | 1.00 | SLC7A5 (0.67) | SLC7A5SLC1A3SLC1A2SLC1A1CACNA2D1 | |
| D-Leucine SCHEMBL4958590 | 0.92 | SLC7A5 (0.78) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Leucine SCHEMBL4775846 | 0.92 | SLC7A5 (0.78) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Leucine SCHEMBL4775848 | 0.92 | SLC7A5 (0.78) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Leucine SCHEMBL6130794 | 0.92 | SLC7A5 (0.78) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| Leucine SCHEMBL6130796 | 0.92 | SLC7A5 (0.78) | SLC7A5SLC1A3SLC1A2SLC1A1GRIK1 | |
| D-Glutamate SCHEMBL28407836 | 0.91 | SLC1A3 (0.55) | SLC7A5SLC1A3SLC1A2SLC1A1CACNA2D1 | |
| D-Leucine SCHEMBL1537345 | 0.90 | SLC7A5 (0.82) | SLC7A5SLC1A3SLC1A2SLC1A1CACNA2D1 | |
| Leucine SCHEMBL625031 | 0.90 | SLC7A5 (0.82) | SLC7A5SLC1A3SLC1A2SLC1A1CACNA2D1 | |
| Leucine SCHEMBL2154089 | 0.90 | SLC7A5 (0.82) | SLC7A5SLC1A3SLC1A2SLC1A1CACNA2D1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11384117-B2 | Connective tissue stimulating peptides | OCTANE ORTHOBIOLOGICS INC. (CA) | 2022-07-12 | — | — | US | claimed |
| US-20190077831-A1 | CONNECTIVE TISSUE STIMULATING PEPTIDES | MILLENIUM BIOLOGIX INC. (CA) | 2019-03-14 | — | — | US | claimed |
| US-10202419-B2 | Connective tissue stimulating peptides | OCTANE ORTHOBIOLOGICS INC. (CA) | 2019-02-12 | — | — | US | claimed |
| US-20160237117-A1 | CONNECTIVE TISSUE STIMULATING PEPTIDES | MILLENIUM BIOLOGIX INC. (CA) | 2016-08-18 | — | — | US | claimed |
| US-20120156276-A1 | Connective tissue stimulating peptides | MILLENIUM BIOLOGIX INC. (CA) | 2012-06-21 | — | — | US | claimed |
| US-20050288229-A1 | Connective Tissue Stimulating Peptides | MILLENIUM BIOLOGIX INC. (CA) | 2005-12-29 | — | — | US | claimed |
| EP-1504033-A2 | CONNECTIVE TISSUE STIMULATING PEPTIDES | MILLENIUM BIOLOGIX INC. (CA) | 2005-02-09 | — | — | EP | claimed |
| WO-2003093314-A2 | CONNECTIVE TISSUE STIMULATING PEPTIDES | MILLENIUM BIOLOGIX INC. (CA) | 2003-11-13 | — | — | WO | claimed |
| US-11384117-B2 | Connective tissue stimulating peptides | OCTANE ORTHOBIOLOGICS INC. (CA) | 2022-07-12 | — | — | US | disclosed |
| US-20190077831-A1 | CONNECTIVE TISSUE STIMULATING PEPTIDES | MILLENIUM BIOLOGIX INC. (CA) | 2019-03-14 | — | — | US | disclosed |
| US-10202419-B2 | Connective tissue stimulating peptides | OCTANE ORTHOBIOLOGICS INC. (CA) | 2019-02-12 | — | — | US | disclosed |
| US-20160237117-A1 | CONNECTIVE TISSUE STIMULATING PEPTIDES | MILLENIUM BIOLOGIX INC. (CA) | 2016-08-18 | — | — | US | disclosed |
| US-9133236-B2 | Connective tissue stimulating peptides | MILLENIUM BIOLOGIX INC. (CA) | 2015-09-15 | — | — | US | disclosed |
| US-20120156276-A1 | Connective tissue stimulating peptides | MILLENIUM BIOLOGIX INC. (CA) | 2012-06-21 | — | — | US | disclosed |
| EP-1584338-B1 | Silicon substituted oxyapatite | WARSAW ORTHOPEDIC INC (US) | 2009-01-21 | — | — | EP | disclosed |
| US-20050288229-A1 | Connective Tissue Stimulating Peptides | MILLENIUM BIOLOGIX INC. (CA) | 2005-12-29 | — | — | US | disclosed |
| US-20050244449-A1 | Silicon substituted oxyapatite | WARSAW ORTHOPEDIC, INC | 2005-11-03 | — | — | US | disclosed |
| EP-1584338-A2 | Silicon substituted oxyapatite | MILLENIUM BIOLOGIX INC. (CA) | 2005-10-12 | — | — | EP | disclosed |
| EP-1504033-A2 | CONNECTIVE TISSUE STIMULATING PEPTIDES | MILLENIUM BIOLOGIX INC. (CA) | 2005-02-09 | — | — | EP | disclosed |
| WO-2003093314-A2 | CONNECTIVE TISSUE STIMULATING PEPTIDES | MILLENIUM BIOLOGIX INC. (CA) | 2003-11-13 | — | — | WO | disclosed |